Navigation Links
R&J Public Relations Named Agency of Record for Aerocrine, Inc.
Date:1/25/2011

BRIDGEWATER, N.J., Jan. 25, 2011 /PRNewswire/ -- Aerocrine, Inc., an innovative medical technology company focused on the treatment of patients with inflamed airways, has selected R&J Public Relations, LLC of Bridgewater, N.J., as its public relations agency of record.  R&J will conduct strategic public relations for the Aerocrine brand; most immediately surrounding the NIOX MINO®, the first and only hand-held device available to measure exhaled nitric oxide (eNO) to aid in asthma management in the United States.

For the first time ever, The NIOX MINO provides doctors the ability to more effectively diagnose, monitor and optimize therapy for individuals suffering from inflammatory airway diseases through one easy-to-use device.  This ground-breaking technology helps eliminate the uncertainties that contribute to asthma morbidity and mortality, including incorrect diagnosis, patient adherence issues, and identifying those patients that will be responsive to treatment.

"Our comprehensive experience and strong presence in the healthcare market space combined with our aggressive and proactive consumer and media relations practices will provide Aerocrine with the leverage they need to elevate their innovative brand and products," said Scott Marioni, Executive Vice President of R&J Public Relations.  "R&J is confident that our strategic public relations will significantly increase the awareness of the Aerocrine brand and NIOX MINO while positioning eNO testing as a standard for patients with asthmatic symptoms."

The founders of Aerocrine originated from the Karolinska Institute in Sweden where they first discovered the significant tie between nitric oxide (NO) and inflammation.  Aerocrine used this discovery as a basis for creating products that assist in the management and care of people afflicted with varying airway inflammatory diseases.

R&J's main objective is to promptly elevate Aerocrine's brand through its established world-wide reputation, and further the awareness of Aerocrine's NIOX MINO products among allergists, pulmonologists, and potential patients. Through a decisive, long-term plan, combined with steadfast public and media relations efforts, R&J will support Aerocrine's growth and product-specific goal.

About Aerocrine

Aerocrine AB is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases. As the pioneer and leader in the technology to monitor and manage airway inflammation, Aerocrine markets NIOX® Flex and NIOX MINO®. Both products enable fast and reliable management of airway inflammation and may therefore play a critical role in more effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases such as asthma. Aerocrine is based in Sweden with subsidiaries in the US, Germany and the UK. Aerocrine shares were listed on the Stockholm Stock Exchange on 15 June 2007. More information can be found online at www.aerocrine.com.

About R&J Public Relations

R&J Public Relations, LLC is a full-service public relations firm that consistently achieves superior results for a strong and diverse client base that ranges from divisions of large, multi-national conglomerates to regional market leaders.  Based in Bridgewater, N.J., with an office in Manhattan, the company has become one of the most respected, admired and prestigious PR agencies in the Greater New York/New Jersey region.  R&J has earned numerous awards for its strategic communications programs and was named a "Top Place to Work in PR" by PR News in 2010. For more information on R&J Public Relations, please visit www.randjpr.com.


'/>"/>
SOURCE R&J Public Relations, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmasset Prices Public Offering of Common Stock
2. Pharmasset Announces Proposed Public Offering of Common Stock
3. Pharmacists Offer Recommendations to Guide Public Through Cold and Flu Season
4. American Scientific Resources, Inc. Announces S-1 Registration Statement Effective; Commences Public Reporting Requirements
5. Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research
6. FDA Warns Public of Continued Extortion Scam By FDA Impersonators
7. Amarin Prices Public Offering of American Depositary Shares
8. Dr. Marianne T. Sweetser Recognized by Strathmores Whos Who Worldwide Publication
9. HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
10. Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors
11. Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):